CIC Philadelphia and Persephoni BioPartners Announce New Strategic Partnership

CIC, a global leader in building and operating innovation communities, and Persephoni BioPartners, a strategic advisory and Biotech venture studio firm, are excited to announce a strategic partnership built around CIC Philadelphia’s location in uCity Square to drive growth and development of early-stage biotech companies in Philadelphia. 

CIC’s commitment to building innovative environments and programs that empower startups and scale-ups to address global and local challenges has established it as one of the world’s premier biotech ecosystems. With locations across three continents, it has supported over 10,000 members since its founding. CIC Philadelphia’s location in uCity Square is home to over 140 companies, ranging from startups to publicly traded firms across diverse industries. Their mission extends beyond providing state of the art facilities and includes diverse programming and opportunities to help members grow their businesses, overcome key developmental challenges, and expand into new markets. 

Persephoni BioPartners is both a venture studio and a strategic consulting firm, with a cross-functional leadership team that combines over 100 years of experience in life sciences research, multiple FDA approvals, having advanced more than 300 therapies to the clinic, and driving numerous M&As, IPOs, and major pharmaceutical transactions and partnerships. They take a hands-on support role, offering strategic guidance and addressing challenges that are often overlooked in early biotech ventures. To provide resident and local startups access to such a model, CIC has partnered with Persephoni BioPartners to provide a landing space and ecosystem for the Persephoni Venture Studio. The program will seek to enable promising young startups in the Greater Philadelphia area by providing them the resources and infrastructure to develop their core technology toward successful fundraising and execution of strategic partnerships. 

“We are incredibly excited to call CIC our home for our Philadelphia operations. Their state of the art facilities will enable our current portfolio companies to accelerate their research and development as we prepare for clinical advancement. We aim to serve across the ecosystem and facilitate cross organizational and institutional collaborations to serve the amazing technologies housed within Philadelphia,” said Hilary Schultz, CEO of Persephoni BioPartners

Persephoni has an office on the 7th floor of CIC Philadelphia at 3675 Market Street in the uCity Square Knowledge Community, where it will serve as a landing pad for the companies in its venture studio program. It will also open its doors to existing CIC members, offering advisory services ranging from startup incorporation and capitalization table structure, strategic planning, regulatory strategy, capital raise, and business development to support strategic partnerships. 

“We are excited to partner with Persephoni BioPartners, an organization aligned with our mission to drive innovation by supporting companies that tackle the world’s most pressing challenges,” said Sarajane Blair, General Manager of CIC Philadelphia. “The Persephoni Venture Studio will offer a wealth of resources and infrastructure and will be a great addition to our CIC Philadelphia community.”

About Persephoni BioPartners, LLC
Persephoni BioPartners is a Venture Studio and strategic consulting and leadership firm dedicated to accelerating innovation in life sciences by bridging the gap between discovery research practices and successful therapeutic development. Specializing in preclinical development strategy, IND execution, intellectual property protection, leadership development, and strategic partnerships. Persephoni empowers research centers, inventors, and growth stage companies to create impactful solutions and drive success from concept to clinic. Persephoni’s leadership combines over 100 years of experience in life sciences research, multiple FDA approvals, advancing more than 300 therapies to the clinic, and driving numerous M&As, IPOs, and major pharmaceutical transactions and partnerships.

Learn more about Persephoni and its leadership at www.persephonibio.com

About CIC

CIC builds and operates a global network of innovation campuses where startups, scale-ups, corporations and public entities connect, work, and grow. Founded in 1999, CIC manages 1.5 million square feet of innovation-focused workspace, laboratories, and event space across North America, Europe and Asia. Additionally, CIC develops bespoke programming, builds and enables industry clusters, and provides world-class district consulting—all focused on advancing innovation.

Learn more about CIC’s innovation campuses featuring workspace & labs, programming, and events at CIC.com. Follow along on LinkedIn, Instagram, and Facebook.

The News Press Releases The Lab Philadelphia North America